Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Protalix Biotherapeutics Inc. buy klostergang

Protalix Biotherapeutics Inc.
Start price
€18.27
08.04.15 / 50%
Target price
€24.00
08.10.15
Performance (%)
-46.14%
End price
€9.84
08.10.15
Summary
This prediction ended on 08.10.15 with a price of €9.84. Massive losses of -46.14% were the result for the BUY prediction by klostergang. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Protalix Biotherapeutics Inc. 8.943% 8.943% 16.068% 85.083%
iShares Core DAX® 1.432% 2.628% 12.457% 60.347%
iShares Nasdaq 100 1.892% -0.458% 1.248% 85.806%
iShares Nikkei 225® -1.619% 11.097% 27.382% 64.398%
iShares S&P 500 1.921% 1.159% 1.635% 59.419%

Comments by klostergang for this prediction

In the thread Protalix Biotherapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -46.14%
Target price 2.400
Change
Ends at 08.10.15

Protalix BioTherapeutics

Protalex recently received FDA clearance to begin a Phase 1/2 study with PRTX-100 in Immune Thrombocytopenia (ITP).

Previous data with PRTX-100 in patients with Rheumatoid Arthritis (RA) demonstrated the drug to be both safe and highly efficacious.

klostergang 
0
Report Share
08.04.15
Prediction Buy
Perf. (%) -46.14%
Target price 2.400
Change
Ends at 08.10.15

(Laufzeit überschritten)

klostergang 
0
Report Share
08.10.15